| |
|
|
|
Pluristem Therapeutc  
|
|
9.87 0.17 (0.02%) |
10-23 16:00 |
|
Open: |
9.79 |
Pre close: |
9.7 |
Target:
|
12.21
|
|
High: |
10 |
Low: |
9.5 |
Resistance:
|
10.46
11.60
|
|
Volume: |
142,836 |
Market Cap: |
252M |
Support:
|
8.61
7.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.23
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
10.44  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
9.40 |
Stochastic Oscillator |
%K(14,3):
|
12.68 |
|
MA(250): |
6.78 |
%D(3): |
27.86 |
|
Average Volume(K) |
3-Month: |
42788
|
52-Week |
High:
|
13.29 |
|
10-Days: |
25537 |
Low: |
2.82 |
|
RSI |
RSI(14):
|
45.21 |
Change(%): |
183.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.600 |
Return on Equity (ttm) |
-74.8 |
Shares Out. (M) |
25.55 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-38.0 |
Shares Float (M) |
17.95 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.15 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.67 |
|
Forward EPS |
-2.900 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
1290 |
|
Book Value (p.s.) |
2.200 |
EBITDA (p.s.) |
-1.092 |
P/E |
-6.17 |
|
Sales Per Share |
0.001 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.49 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.37 |
P/S |
10964.28 |
|
Operating Margin |
-128156.52 |
Levered Free Cash Flow
(M) |
-15.88 |
P/CF |
-9.56 |
|
|
|
|
|
|
